Clinical Trial: A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Plaque Psoriasis
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Multi-center, Open-label, Single-arm Study to Assess the Safety of Apremilast (AMG 407) in Pediatric Participants From 6 Through 17 Years of Age With Mild to Moderate Plaque Psoriasis
Brief Summary:
The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 17 years) with mild to moderate plaque psoriasis.
Read more